Capstan is a biotechnology company with a mission to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. Our CellSeeker™ tLNP platform technology comprises proprietary targeted lipid nanoparticles (tLNP) that are composed of LNPs conjugated with a recombinant protein binder, such as a monoclonal antibody. tLNPs are designed to deliver payloads, including mRNA or gene editing tools, capable of reprogramming specific cell types in vivo. Capstan’s CellSeeker™ technology has the potential to generate transformative therapies with possible applications across a broad range of disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. For more information, please visit www.capstantx.com.
Company Details
- Employees
- 107
- Founded
- -
- Address
- San Diego, California, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.capstantx.com/
- HQ
- San Diego, California
Capstan Therapeutics Questions
Capstan Therapeutics's website is https://www.capstantx.com/
Capstan Therapeutics's LinkedIn profile is https://www.linkedin.com/company/capstan-therapeutics
Capstan Therapeutics has
107 employees.
View email and phone details for 107
employees at Capstan Therapeutics.
Capstan Therapeutics's industry is
Biotechnology Research
Capstan Therapeutics's top competitors are
Artiva Biotherapeutics,
Arcturus Therapeutics,
Avidity Biosciences, Inc.,
Engrail Therapeutics,
Poseida Therapeutics, Inc.,
Abbvie,
Avenzo Therapeutics,
Mirador Therapeutics,
Fate Therapeutics Inc.,
Neurocrine Biosciences.
Capstan Therapeutics's categories are Biotechnology Research
Capstan Therapeutics's founding year is 2021
